靶向Src SH3结构域介导的HSC糖酵解抑制转录组、肌成纤维细胞活化及结直肠癌肝转移
TGFβ1诱导肝星状细胞活化为促转移的癌相关成纤维细胞,伴随质膜Glut1升高和糖酵解增强。靶向Glut1或Src(敲低、药物抑制或删除Src SH3结构域)可阻断TGFβ1刺激的质膜Glut1累积、糖酵解和CAF活化。机制上Src SH3结构域与SH3BP5结合形成Src/SH3BP5/Rab11/Glut1复合物,激活Rab11依赖的Glut1质膜转运。HSC特异性Glut1缺失或Src SH3结构域缺失抑制小鼠CAF活化和MC38结直肠癌肝转移。
要点
- TGFβ1通过Src SH3结构域-SH3BP5-Rab11轴促进Glut1质膜转运和HSC糖酵解。
- 靶向Glut1或Src SH3结构域可阻断HSC向CAF活化。
- HSC/CAF的Glut1缺失抑制促肿瘤因子表达并减少MC38肝转移。
核心结论
- TGFβ1诱导的Src SH3结构域介导的代谢重编程是抑制CAF活化和促转移肝脏微环境的靶点。
研究设计与样本
- 体外使用原代人HSC活化模型,检测肌成纤维细胞标志物。
- 体内采用HSC特异性Glut1敲除小鼠(Cre/LoxP),进行皮下HSC/肿瘤共植入和门静脉注射MC38结直肠癌细胞。
- 使用生物素化实验和Seahorse XFe96分析仪检测质膜Glut1和糖酵解。
- 通过RNA测序和空间组学分析HSC转录组及MC38肝转移灶。
主要发现
- TGFβ1诱导的HSC的CAF活化伴随质膜Glut1、葡萄糖摄取和糖酵解升高。
- 敲低或药物抑制Glut1或Src,或使用Src SH3结构域缺失突变体,可消除TGFβ1刺激的质膜Glut1累积、糖酵解和CAF活化。
- Src SH3结构域与SH3BP5结合形成Src/SH3BP5/Rab11/Glut1复合物,激活Rab11依赖的Glut1质膜转运。
- 删除Src SH3结构域或靶向HSC的Glut1(shRNA或Cre/LoxP)抑制小鼠CAF活化和MC38结直肠癌肝转移。
- 多组学显示HSC/CAF中Glut1缺陷抑制HSC促肿瘤因子表达并改变MC38转录组,减少MC38肝转移。
临床怎么用
- 靶向Src SH3结构域或HSC/CAF的Glut1可能成为抑制CAF活化和结直肠癌肝转移的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Transforming growth factor-beta 1 (TGFβ1) induces HSC activation into metastasis-promoting cancer-associated fibroblasts (CAFs), but how the process is fueled remains incompletely understood. We studied metabolic reprogramming induced by TGFβ1 in HSCs. APPROACHES AND RESULTS: Activation of cultured primary human HSCs was assessed by the expression of myofibroblast markers. Glucose transporter 1 (Glut1) of murine HSC was disrupted by Cre recombinase/LoxP sequence derived from bacteriophage P1 recombination (Cre/LoxP). Plasma membrane (PM) Glut1 and glycolysis were studied by biotinylation assay and the Angilent Seahorse XFe96 Analyzer. S.c. HSC/tumor co-implantation and portal vein injection of MC38 colorectal cancer cells into HSC-specific Glut1 knockout mice were performed to determine in vivo relevance. Transcriptome was obtained by RNA sequencing of HSCs and spatialomics with MC38 liver metastases. TGFβ1-induced CAF activation of HSCs was accompanied by elevation of PM Glut1, glucose uptake, and glycolysis. Targeting Glut1 or Src by short hairpin RNA, pharmacologic inhibition, or a Src SH3 domain deletion mutant abrogated TGFβ1-stimulated PM accumulation of Glut1, glycolysis, and CAF activation. Mechanistically, binding of the Src SH3 domain to SH3 domain-binding protein 5 led to a Src/SH3 domain-binding protein 5/Rab11/Glut1 complex that activated Rab11-dependent Glut1 PM transport under TGFβ1 stimulation. Deleting the Src SH3 domain or targeting Glut1 of HSCs by short hairpin RNA or Cre recombinase/LoxP sequence derived from bacteriophage P1 recombination suppressed CAF activation in mice and MC38 colorectal liver metastasis. Multi-omics revealed that Glut1 deficiency in HSCs/CAFs suppressed HSC expression of tumor-promoting factors and altered MC38 transcriptome, contributing to reduced MC38 liver metastases. CONCLUSION: The Src SH3 domain-facilitated metabolic reprogramming induced by TGFβ1 represents a target to inhibit CAF activation and the pro-metastatic liver microenvironment.
引用
- Wang Y, Wang X, Bai B, et al. Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis. Hepatology. 2024. PMID: 38271673. doi:10.1097/HEP.0000000000000763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。